OUR DREAM
We, as Lions and Lionesses of the Lionhealth SB team, want to build a market-leading health-tech company that develops products and solutions capable of addressing the specific needs of malnutrition for patients with various diseases by combining science, plant extracts, and ESG culture.
THE TEAM.
Founder
Paola Lanati
- 11 years as a marketer & executive in multinational companies: P&G, Astrazeneca, UCB, BMS and Amgen
- In 2010, he founded a group of companies that became leaders in consulting and services to the healthcare world, from which he exited in 2021
- Since 2022, she has been a business angel and investor in start-ups
- Vice President Italian Angels for Biotech (IAB)
- Included in Forbes Italy's 100 winning leaders
- Named among 50 Italian women in the international Inspiringfifty award
The People
Our team consists of Lionesses and Lions who believe in the project and put their hearts and heads into making it happen. It is structured to follow the product development 360 degrees, from formulation to marketing. It consists of 4 macro-areas:
- R&D & Medical Affair
- Marketing & Brand Development
- Supply Chain & Operations Planning
- Sales & Market Access
Scientific Committee
Alexander Armuzzi
Director UOC IBD Humanitas Research Hospital
Riccardo Caccialanza
Director SC Dietetics and Clinical Nutrition Fondazione IRCCS Policlinico San Matteo
Antonio Gasbarrini
Full Professor of Internal Medicine, Catholic University of the Sacred Heart.
Director UOC Internal Medicine and Gastroenterology and CEMAD, Fondazione Policlinico Universitario A. Gemelli IRCCS
Salvo Leone
Director General Association AMICI Italy
Maurizio Muscaritoli
Carmine Pinto
Medical Oncology Director, Comprehensive Cancer Centre, AUSL-IRCCS of Reggio Emilia
Former president AIOM(Italian Association of Medical Oncology)
research & pipeline
Lionhealth SB has decided to focus its R&D efforts on the development of products and solutions against Disease Related Malnutritions (DRM).
At the end of 2022, Lionhealth SB acquired from IRCCS Policlinico Gemelli Foundation, Gemelli Health System company that has developed 13 Food for special medical purposes (FSMPs) dedicated with patented matrix.
According to ESPEN, DRM are disease-related forms of malnutrition, resulting in loss of weight and muscle mass, physical dysfunction, and leading to worse clinical outcomes. The prevalence of DRM varies between 20% and 80%, depending on the disease.
Our research focused in these areas:
ONCOLOGY
RARE DISEASES.
DISEASES OF THE CENTRAL NERVOUS SYSTEM
Both in vitro studies on human cell line models and clinical studies for scientific validation of products are underway, in collaboration with Italian universities and hospitals.
In 2023, Lionhealth SB spent 36 percent of its investment on pure research and development.
ESG
Lionhealth as a Benefit Company is committed to promoting ESG culture through the benefit plan.
The following are the main activities and relevant documents.
-
Supply chain designed with attention to environmental sustainability.
Our choices are aimed at reducing environmental impact: from recyclable packaging, to the use of recycled paper, to secondary packaging to reduce waste
- Measuring and neutralizing the Carbon Footprint
-
Adoption of ZED (Zero Emission Digital) Protocol
Website digital estrategies designed to improve environmental sustainability, targeted use of email to reduce the number of mailings.
- Collaboration with Italian universities and hospitals
- Lionhealth Award disbursement: scholarship intended for a University of Pavia undergraduate and Collegio Nuovo alumna with thesis project dedicated to nutrition issues
-
Made in Italy
Italian supply chain at all stages: research, prototyping, production, logistics, distribution
- Membership in trade associations
AWARDS
